NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/10/2026
Back to search
Official data from USPTO
NOVARTIS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
02/11/2026
Trademark type
Combined
Nice classes
42, 44
Filing date
12/11/2023
Registration date
02/10/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/10/2026
Last transaction
02/11/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/31/2017
First use in commerce
03/31/2017
Drawing code
3
Owner type
99
Owner location
Basel, CH
Examiner
SONNEBORN, TRICIA L
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized presentation of a mortar and pestle to the left of the stylized word "NOVARTIS". The mortar is depicted in orange and yellow, with the top left of the mortar in orange and transitioning to yellow in a counter-clockwise direction. The pestle is shown in blue. The word "NOVARTIS" is presented in capital letters in blue.
Holders and representatives
Holders
Novartis AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and pharmaceutical research services; pharmaceutical research and development
Class 44
Providing medical and health information via a website; providing a website featuring information in the field of the diagnosticprophylactic and therapeutic properties of pharmaceuticals; Providing information in the medical field and information in the field of the diagnosticprophylactic and therapeutic properties of pharmaceuticals; Providing health information; Providing patients with medical and health information in the medical field.
Publications
History of USPTO decisions and trademark events.
31 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/10/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
01/20/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
01/20/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/31/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
12/31/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/30/2025
IUAF
USE AMENDMENT FILED
07/01/2025
DRRR
DIVISIONAL REQUEST RECEIVED
07/01/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
07/01/2025
EISU
TEAS STATEMENT OF USE RECEIVED
07/01/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/07/2025
EX1G
SOU EXTENSION 1 GRANTED
01/07/2025
EXT1
SOU EXTENSION 1 FILED
01/07/2025
EEXT
SOU TEAS EXTENSION RECEIVED
01/07/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/14/2024
PUBO
PUBLISHED FOR OPPOSITION
05/14/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/09/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
04/09/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/09/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
04/09/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/09/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/08/2024
GNRT
NON-FINAL ACTION E-MAILED
04/08/2024
CNRT
NON-FINAL ACTION WRITTEN
04/08/2024
DOCK
ASSIGNED TO EXAMINER
03/20/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/12/2024
NWAP
NEW APPLICATION ENTERED
12/11/2023
Continuous trademark protection
Get notified about every new filing that threatens NOVARTIS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.